Delivery Order SPE2DB20D2104-SPE2DB25FMXSY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,073.79 for Fluticasone Propionate 50 MCG Spray in 16GM units, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in a 16-gram formulation, valued at $2,168.37. The award was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,442.72 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 grams) on August 13, 2025, with an ultimate completion date of August 14, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,415.56 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16GM units. The contract was competitively awarded without set-aside designation under firm fixed price terms, with an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction within the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,437.83 for Fluticasone Propionate 50 micrograms spray (16 grams) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,131.74 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16 grams) on August 8, 2025, with a completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction for a common respiratory...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 grams) with a ceiling value of $1,026.73. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 15, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under AmerisourceBergen's Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,165.50 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate 50 MCG Spray (16 grams). This is a firm fixed-price, non-set-aside contract with a completion date of July 31, 2025, and was awarded on July 30, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.61 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a direct fulfillment order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXSYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) under a firm fixed-price contract valued at $1,141.34. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. This award is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare programs and other federal health systems worldwide. AmerisourceBergen's consistent track record of competitively awarded delivery orders across multiple therapeutic domains demonstrates its capability to meet federal pharmaceutical distribution requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/13/25 |